Testosterone regulation of Alzheimer-like neuropathology in male 3xTg-AD mice involves both estrogen and androgen pathways.
Normal, age-related depletion of the androgen testosterone is a risk factor for Alzheimer's disease (AD) in men. Previously, we reported that experimental androgen depletion significantly accelerates development of AD-like neuropathology in the 3xTg-AD triple-transgenic mouse model of AD, an effect prevented by androgen treatment. Because testosterone is metabolized in brain into both the androgen dihydrotestosterone (DHT) and the estrogen 17β-estradiol (E2), testosterone can mediate its effects through androgen and or estrogen pathways. To define the role of androgen and estrogen pathways in regulation of AD-like neuropathology, we compared the effects of testosterone (T) and its metabolites DHT and E2 in male 3xTg-AD mice depleted of endogenous sex steroid hormones by gonadectomy (GDX). Male 3xTg-AD mice were sham GDX or GDX, immediately treated with vehicle, T, DHT, or E2, and 4 months later evaluated for two indices of AD-like neuropathology, β-amyloid (Aβ) accumulation and tau hyperphosphorylation. In comparison to sham GDX mice, we observed a significant increase in Aβ accumulation in GDX mice in subiculum, hippocampus, and amygdala. Treatment of GDX mice with T prevented the increased Aβ accumulation in all three brain regions. DHT treatment yielded similar results, significantly reducing Aβ accumulation across brain regions. Interestingly, E2 prevented Aβ accumulation in hippocampus but exerted only partial effects in subiculum and amygdala. Levels of tau hyperphosphorylation in sham GDX male 3xTg-AD mice were modest and only slightly increased by GDX. Treatment of GDX mice with T or E2 but not DHT reduced tau hyperphosphorylation to levels lower than observed in sham animals. These data suggest that testosterone regulates Aβ pathology through androgen and estrogen pathways and reduces tau pathology largely through estrogen pathways. These findings further define hormone pathways involved in regulation of AD-related pathology, information that is important for understanding disease etiology and developing pathway-specific hormone interventions.
Rosario
Emily R
ER
Neuroscience Graduate Program, Davis School of Gerontology, University of Southern California, Los Angeles, CA 90089, USA.
Carroll
Jenna
J
Pike
Christian J
CJ
D000544:Alzheimer Disease / Q000378:metabolism* / Q000473:pathology; D016229:Amyloid beta-Peptides / Q000378:metabolism; D000818:Animals; D001921:Brain / Q000378:metabolism* / Q000473:pathology; D013196:Dihydrotestosterone / Q000378:metabolism* / Q000494:pharmacology; D004195:Disease Models, Animal; D004958:Estradiol / Q000378:metabolism* / Q000494:pharmacology; D007150:Immunohistochemistry; D008297:Male; D051379:Mice; D008822:Mice, Transgenic; D010766:Phosphorylation; D015398:Signal Transduction / Q000502:physiology; D013739:Testosterone / Q000378:metabolism* / Q000494:pharmacology; D016875:tau Proteins / Q000378:metabolism
D016229:Amyloid beta-Peptides; D016875:tau Proteins; D013196:Dihydrotestosterone; D013739:Testosterone; D004958:Estradiol
Neurobiol Aging. 2003 Dec;24(8):1063-70
14643377
Neuroscience. 2003;122(3):573-8
14622899
J Clin Endocrinol Metab. 2007 Mar;92(3):1049-57
17164307
Front Neuroendocrinol. 1998 Oct;19(4):323-62
9799588
JAMA. 2004 Sep 22;292(12):1431-2
15383512
J Neurosci. 2006 Dec 20;26(51):13384-9
17182789
Methods Mol Biol. 2003;222:211-22
12710689
J Alzheimers Dis. 2003 Aug;5(4):267-9
14624021
Proc Natl Acad Sci U S A. 2002 Oct 15;99(21):13589-94
12370428
Horm Behav. 2008 May;53(5):693-705
18222446
J Neurosci. 2007 Nov 28;27(48):13357-65
18045930
Ann Neurol. 1986 May;19(5):415-24
3717905
Am J Pathol. 2007 May;170(5):1669-75
17456772
Endocr Rev. 2005 Oct;26(6):833-76
15901667
J Neuroendocrinol. 2004 Feb;16(2):93-4
14763993
Neurobiol Aging. 2002 Mar-Apr;23(2):161-70
11804699
Neurology. 2005 Jun 28;64(12):2063-8
15985573
J Cereb Blood Flow Metab. 2009 Aug;29(8):1359-72
19458604
Pharmacol Rev. 2000 Dec;52(4):513-56
11121509
J Clin Endocrinol Metab. 2006 Jun;91(6):1995-2010
16720669
J Neurochem. 2003 Nov;87(4):1052-5
14622134
Horm Behav. 2008 May;53(5):741-52
18067894
J Neuroendocrinol. 2000 Apr;12(4):351-4
10718932
Proc Natl Acad Sci U S A. 2000 Feb 1;97(3):1202-5
10655508
Brain Res Rev. 2008 Mar;57(2):444-53
17658612
J Neurochem. 2008 Jun 1;105(6):2477-88
18346198
Scand J Clin Lab Invest. 2008;68(8):814-22
18821130
Proc Natl Acad Sci U S A. 2002 Feb 5;99(3):1140-5
11805297
Exp Neurol. 2003 Jun;181(2):301-12
12782002
Neuroscience. 2006;138(3):929-38
16310316
Ann N Y Acad Sci. 2005 Dec;1055:80-92
16387720
Psychoneuroendocrinology. 2004 Sep;29(8):1019-27
15219653
J Neurosci. 2004 Jan 14;24(2):495-9
14724248
Neurobiol Aging. 2011 Nov;32(11):1949-63
20053478
J Alzheimers Dis. 2008 Sep;15(1):129-37
18780973
Endocrinology. 1995 Aug;136(8):3213-21
7628354
J Neurosci. 1994 Dec;14(12):7680-7
7996203
Proc Natl Acad Sci U S A. 2001 May 22;98(11):6330-5
11371645
Horm Behav. 2008 May;53(5):706-15
18395206
J Neurosci. 1992 Jul;12(7):2549-54
1613547
J Steroid Biochem Mol Biol. 1993 Feb;44(2):105-12
8439515
Behav Neurosci. 2004 Dec;118(6):1352-64
15598144
Learn Mem. 2009 Jul 24;16(8):479-85
19633137
JAMA. 2001 May 2;285(17):2195-6
11325319
J Neuroendocrinol. 2009 Mar;21(4):351-8
19207807
Endocrine. 2005 Apr;26(3):317-26
16034187
J Neurosci. 2005 Sep 28;25(39):8843-53
16192374
Neuroscience. 2006;138(3):1015-20
16310318
JAMA. 1989 Nov 10;262(18):2551-6
2810583
Endocrinology. 1976 Apr;98(4):864-74
179788
Brain Res. 2005 Sep 14;1056(1):22-35
16122717
J Neurosci. 2008 Aug 20;28(34):8430-41
18716201
J Comp Neurol. 1997 Dec 1;388(4):507-25
9388012
Ann N Y Acad Sci. 2005 Jun;1052:210-24
16024764
J Steroid Biochem. 1986 Mar;24(3):703-8
3702447
Endocrinology. 2005 Jan;146(1):147-55
15471969
J Biol Chem. 2006 Dec 22;281(51):39413-23
17056594
J Neurochem. 1999 Apr;72(4):1552-63
10098861
Front Neuroendocrinol. 2009 Jul;30(2):239-58
19427328
J Androl. 2003 Jul-Aug;24(4):568-76
12826696
Trends Neurosci. 1997 Apr;20(4):154-9
9106355
Endocrinology. 2008 May;149(5):2607-11
18276750
J Neurosci. 2003 Mar 1;23(5):1588-92
12629162
Proc Natl Acad Sci U S A. 1997 Jun 24;94(13):6612-7
9192613
Neurobiol Aging. 2011 Apr;32(4):604-13
19428144
Neurochem Res. 2008 Sep;33(9):1811-20
18338250
Acta Psychiatr Scand. 1987 Nov;76(5):465-79
3324647
Neuron. 2003 Jul 31;39(3):409-21
12895417
J Neurosci. 2006 Feb 1;26(5):1448-56
16452668
J Comp Neurol. 1990 Apr 1;294(1):76-95
2324335
Brain Res. 2001 Nov 16;919(1):160-5
11689174
Trends Cogn Sci. 2006 Feb;10(2):77-82
16386941
Neurosci Lett. 2000 Dec 15;296(1):49-52
11099831